These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37855352)

  • 1. Fluorinated Diaryl Sulfonamides: Molecular Modeling, Synthesis, and
    Khalaf RA; Shalluf A; Habash M
    Curr Comput Aided Drug Des; 2024; 20(6):987-997. PubMed ID: 37855352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trifluoromethylated Aryl Sulfonamides as Novel CETP Inhibitors: Synthesis, Induced Fit Docking, Pharmacophore Mapping and Subsequent
    Khalaf RA; Shaiah HA; Sabbah D
    Med Chem; 2023; 19(4):393-404. PubMed ID: 36093822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Synthesis, Biological Evaluation, and Cheminformatics Analysis of a Group of Chlorinated Diaryl Sulfonamides: Promising Inhibitors of Cholesteryl Ester Transfer Protein.
    Abu Khalaf R; Lafi A; Hajjo R; Al-Sha'er MA
    Curr Comput Aided Drug Des; 2024 Feb; ():. PubMed ID: 38424428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors.
    Abu Khalaf R; Sabbah D; Al-Shalabi E; Bishtawi S; Albadawi G; Abu Sheikha G
    Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29112287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors.
    Abu Khalaf R; Abusaad A; Al-Nawaiseh B; Sabbah D; Albadawi G
    Curr Comput Aided Drug Des; 2024; 20(5):564-574. PubMed ID: 37165488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors.
    Khalaf RA; Al-Rawashdeh S; Sabbah D; Abu Sheikha G
    Med Chem; 2017; 13(3):239-253. PubMed ID: 27823564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer protein (CETP) inhibitors based on cyclic urea, bicyclic urea and bicyclic sulfamide cores.
    Liu J; Shao PP; Guiadeen D; Krikorian A; Sun W; Deng Q; Cumiskey AM; Duffy RA; Murphy BA; Mitra K; Johns DG; Duffy JL; Vachal P
    Bioorg Med Chem Lett; 2021 Jan; 32():127668. PubMed ID: 33161125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.
    Poliakova T; Wellington CL
    Mol Neurodegener; 2023 Nov; 18(1):86. PubMed ID: 37974180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.
    Johns DG; Duffy J; Fisher T; Hubbard BK; Forrest MJ
    Drugs; 2012 Mar; 72(4):491-507. PubMed ID: 22356288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Molecular Modeling of Novel 3,5-Bis(trifluoromethyl) benzylamino Benzamides as Potential CETP Inhibitors.
    Khalaf RA; Awad M; Al-Qirim T; Sabbah D
    Med Chem; 2022; 18(4):417-426. PubMed ID: 34463228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.
    Mabuchi H; Nohara A; Inazu A
    Mol Cells; 2014 Nov; 37(11):777-84. PubMed ID: 25410905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
    Mohammadpour AH; Akhlaghi F
    Clin Pharmacokinet; 2013 Aug; 52(8):615-26. PubMed ID: 23658137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How anacetrapib inhibits the activity of the cholesteryl ester transfer protein? Perspective through atomistic simulations.
    Äijänen T; Koivuniemi A; Javanainen M; Rissanen S; Rog T; Vattulainen I
    PLoS Comput Biol; 2014 Nov; 10(11):e1003987. PubMed ID: 25412509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the mechanisms of cholesteryl ester transfer protein inhibitors.
    Zhang M; Lei D; Peng B; Yang M; Zhang L; Charles MA; Rye KA; Krauss RM; Johns DG; Ren G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Dec; 1862(12):1606-1617. PubMed ID: 28911944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
    Xue H; Zhang M; Liu J; Wang J; Ren G
    Curr Atheroscler Rep; 2023 Apr; 25(4):155-166. PubMed ID: 36881278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.
    Shinkai H
    Vasc Health Risk Manag; 2012; 8():323-31. PubMed ID: 22661899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and SAR studies of ursolic acid 3β-ester derivatives as novel CETP inhibitors.
    Chen C; Sun R; Sun Y; Chen X; Li F; Wen X; Yuan H; Chen D
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126824. PubMed ID: 31780304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.
    Chapman MJ; Le Goff W; Guerin M; Kontush A
    Eur Heart J; 2010 Jan; 31(2):149-64. PubMed ID: 19825813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of cholesteryl ester transfer protein in complex with inhibitors.
    Liu S; Mistry A; Reynolds JM; Lloyd DB; Griffor MC; Perry DA; Ruggeri RB; Clark RW; Qiu X
    J Biol Chem; 2012 Oct; 287(44):37321-9. PubMed ID: 22961980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.